A new meta-analysis of more than 6000 studies shows that oral contraceptives significantly reduce the risk of ovarian cancer. The risk reduction increases proportionally with duration of use.
See the abstract here
Related Topics
OCRA’s Advocate’s Corner: January 2026
Written by Chad Ramsey, OCRA’s Vice President, Policy OCRA’s Advocate Leader Program Reaches Record Size in 2026 January marked a major milestone for Ovarian Cancer Research Alliance’s (OCRA) advocacy community. OCRA trained 94 new advocates to join our Advocate Leaders program, bringing our total to 227 advocates across 44 states and Washington, DC. This is … Continued
OCRA-Funded Study Provides Clear New Evidence That Opportunistic Salpingectomy Drastically Reduces Risk of Ovarian Cancer
A new study published February 2 in JAMA Network Open provides the clearest evidence to date that opportunistic salpingectomy—the removal of the fallopian tubes during another gynecologic surgery—can dramatically reduce the risk of ovarian cancer. Led by a B.C.-based international collaboration known as the Ovarian Cancer Observatory, the study found that people who underwent opportunistic … Continued
Action Alert: Urge Congress to Pass Final Bill on Cancer Research Funding and Early Detection
This action alert is now closed. View an update on the FY2026 funding package. The Congressional Appropriations Committees have released a combined FY2026 Defense/Labor, Health and Human Services bill—and it includes several critical investments and policy provisions that would significantly strengthen the federal response to ovarian and other gynecologic cancers. This bill represents meaningful progress … Continued